Risk of Hypertension in Patients With MS Treated With Teriflunomide vs Dimethyl Fumarate
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark
Mult. Scler. 2024 Dec 04;[EPub Ahead of Print], E Framke, F Sellebjerg, M Kant, M Stilund, HB Jensen, Z Illes, N Asgari, T Sejbaek, LC Roug, MB Jensen, J Schäfer, PV Rasmussen, JR Christensen, A Weglewski, S Prakash, M MagyariFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.